Find Nebivolol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

184RELATED EXCIPIENT COMPANIES

305EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 169293-50-9, Nebivolol hcl, 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) hydrochloride, 152520-56-4, Rac nebivolol hydrochloride, R 065824 hydrochloride
Molecular Formula
C22H26ClF2NO4
Molecular Weight
441.9  g/mol
InChI Key
JWEXHQAEWHKGCW-UHFFFAOYSA-N

Nebivolol
A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
1 2D Structure

Nebivolol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol;hydrochloride
2.1.2 InChI
InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H
2.1.3 InChI Key
JWEXHQAEWHKGCW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 67555, R

2. Alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2h-1-benzopyran-2-methanol

3. Bystolic

4. Hydrochloride, Nebivolol

5. Lobivon

6. Nebilet

7. Nebivolol

8. R 67555

9. R-67555

10. R67555

11. Silostar

2.2.2 Depositor-Supplied Synonyms

1. 169293-50-9

2. Nebivolol Hcl

3. 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) Hydrochloride

4. 152520-56-4

5. Rac Nebivolol Hydrochloride

6. R 065824 Hydrochloride

7. Nebilox

8. Rac-nebivolol Hcl

9. R-067555

10. Schembl514784

11. N-phenyliminodiaceticacid

12. Chembl1201731

13. Akos016006035

14. Ac-4233

15. Ac-5636

16. Ccg-214847

17. Ro67555

18. As-12100

19. Cs-0362720

20. Ft-0652243

21. Ft-0655833

22. 520n564

23. W-60374

24. J-010524

25. 1-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)-2-hydroxyethyl]amino]ethanol;hydrochloride

26. 2h-1-benzopyran-2-methanol,a,a'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-,hydrochloride(1:1)

27. Alpha,alpha'[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2h-1-benzopyran-2-methanol]hydrochloride

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 441.9 g/mol
Molecular Formula C22H26ClF2NO4
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass441.1518423 g/mol
Monoisotopic Mass441.1518423 g/mol
Topological Polar Surface Area71 Ų
Heavy Atom Count30
Formal Charge0
Complexity483
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count4
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic beta-1 Receptor Agonists

Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
beta-Adrenergic Blocker [EPC]; Adrenergic beta-Antagonists [MoA]

API SUPPLIERS

read-more
read-more

01

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

02

Rampex Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

03

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

04

Gonane Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Gonane Pharma

05

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

06

Octavius Pharma Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Octavius Pharma

07

Honour Lab Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT arrow-down
Company Banner

08

Shamrock Pharmachemi

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

09

CordenPharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

CordenPharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

10

Smaart Pharmaceutticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Smaart Pharmaceutticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Through the acquisition of Nebivolol HCl, targeting the Beta-2 adrenergic receptor, the deal aims to advance hypertension treatment.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Senores Pharmaceuticals

Deal Size: $1.6 million Upfront Cash: Undisclosed

Deal Type: Acquisition December 17, 2025

blank

01

Apnar Pharma

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Apnar Pharma

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Details : Through the acquisition of Nebivolol HCl, targeting the Beta-2 adrenergic receptor, the deal aims to advance hypertension treatment.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

December 17, 2025

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 08, 2024

blank

02

Bio-innova

Thailand
arrow
AACR Annual meeting
Not Confirmed

Bio-innova

Thailand
arrow
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 08, 2024

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Nebivolol,Ramipril

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 27, 2023

blank

03

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 27, 2023

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Nebivolol,Amlodipine

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 24, 2022

blank

04

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 24, 2022

blank

Details:

Zofenopril is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Zofenopril,Nebivolol

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 25, 2022

blank

05

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Menarini

Italy
arrow
AACR Annual meeting
Not Confirmed

Details : Zofenopril is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 25, 2022

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Glaucoma, Open-Angle.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Trial Runners, LLC | Summit Analytical LLC

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 02, 2021

blank

06

Betaliq

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Betaliq

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Lead Product(s) : Nebivolol,Inapplicable

Therapeutic Area : Ophthalmology

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : Trial Runners, LLC | Summit Analytical LLC

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Glaucoma, Open-Angle.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 02, 2021

blank

Details:

DWN12088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Idiopathic Pulmonary Fibrosis.


Lead Product(s): DWN12088,Nebivolol

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 17, 2021

blank

07

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : DWN12088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Idiopathic Pulmonary Fibrosis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 17, 2021

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2018

blank

08

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2018

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2018

blank

09

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2018

blank
  • Development Update

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Heart Failure.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Menarini

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 02, 2015

blank

10

Dong-A University

Country
arrow
AACR Annual meeting
Not Confirmed

Dong-A University

Country
arrow
AACR Annual meeting
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 02, 2015

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

AbbVie Inc

U.S.A

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Brand Name : BYVALSON

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE;80MG

Packaging :

Approval Date : 2016-06-03

Application Number : 206302

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

02

AbbVie Inc

U.S.A

NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

Brand Name : BYSTOLIC

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2398990

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Abbvie Company Banner

03

AbbVie Inc

U.S.A

NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

Brand Name : BYSTOLIC

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2399008

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Abbvie Company Banner

04

AbbVie Inc

U.S.A

NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

Brand Name : BYSTOLIC

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 30

Approval Date :

Application Number : 2399016

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Abbvie Company Banner

05

AbbVie Inc

U.S.A

NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

Brand Name : BYSTOLIC

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 30

Approval Date :

Application Number : 2399024

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Abbvie Company Banner

06

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2007-12-17

Application Number : 21742

Regulatory Info : RX

Registration Country : USA

Abbvie CB

07

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2007-12-17

Application Number : 21742

Regulatory Info : RX

Registration Country : USA

Abbvie CB

08

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2007-12-17

Application Number : 21742

Regulatory Info : RX

Registration Country : USA

Abbvie CB

09

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2008-10-08

Application Number : 21742

Regulatory Info : RX

Registration Country : USA

Abbvie CB

10

Nebivolol Hydrochloride

Brand Name : Nebivolol \"Orion\"

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 12-12-2007

Application Number : 28104095707

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

ABBVIE

U.S.A

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Brand Name : BYVALSON

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE;80MG

Approval Date : 2016-06-03

Application Number : 206302

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Abbvie Company Banner

02

ALLERGAN

U.S.A

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2007-12-17

Application Number : 21742

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie CB

03

ALLERGAN

U.S.A

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2007-12-17

Application Number : 21742

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie CB

04

ALLERGAN

U.S.A

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2007-12-17

Application Number : 21742

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie CB

05

ALLERGAN

U.S.A

NEBIVOLOL HYDROCHLORIDE

Brand Name : BYSTOLIC

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Approval Date : 2008-10-08

Application Number : 21742

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie CB

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

NEBIVOLOL HYDROCHLORIDE

Brand Name : NEBIVOLOL HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2022-11-14

Application Number : 216172

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

NEBIVOLOL HYDROCHLORIDE

Brand Name : NEBIVOLOL HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2022-11-14

Application Number : 216172

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

NEBIVOLOL HYDROCHLORIDE

Brand Name : NEBIVOLOL HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2022-11-14

Application Number : 216172

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

NEBIVOLOL HYDROCHLORIDE

Brand Name : NEBIVOLOL HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Approval Date : 2022-11-14

Application Number : 216172

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Company Banner

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NEBIVOLOL HYDROCHLORIDE

Brand Name : NEBIVOLOL HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Approval Date : 2017-05-25

Application Number : 203821

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 5MG BASE;80MG

USFDA APPLICATION NUMBER - 206302

read-more

DOSAGE - TABLET;ORAL - EQ 10MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 2.5MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 20MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 5MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Topical

read-more
read-more

API Stability Enhancers

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Regulatory FDF Prices

read-more
read-more

01

Brand Name : NEBIVOLOLO THINKS

Japan
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Flag Japan
Digital Content Digital Content

RX/OTC/DISCN :

Nebivolol

Dosage Form : Tablets

Dosage Strength : 5 mg

Price Per Pack (Euro) : 6.1

Published in :

Country : Italy

RX/OTC/DISCN :

Towa Pharmaceutical

02

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablet

Dosage Strength : 5mg+25mg

Price Per Pack (Euro) : 5.97

Published in :

Country : Italy

RX/OTC/DISCN :

blank

03

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablet

Dosage Strength :

Price Per Pack (Euro) : 5.97

Published in :

Country : Italy

RX/OTC/DISCN :

blank

04

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/12.5 mg

Price Per Pack (Euro) : 5.97

Published in :

Country : Italy

RX/OTC/DISCN :

blank

05

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : NEBIVOLOL AND HYDROCHLOROTHI...

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/25 mg

Price Per Pack (Euro) : 5.97

Published in :

Country : Italy

RX/OTC/DISCN :

blank

06

Brand Name : ALONEB

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : ALONEB

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/12.5 mg

Price Per Pack (Euro) : 8.18

Published in :

Country : Italy

RX/OTC/DISCN :

blank

07

Brand Name : LOBIDIUR

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : LOBIDIUR

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/12.5 mg

Price Per Pack (Euro) : 8.18

Published in :

Country : Italy

RX/OTC/DISCN :

blank

08

Brand Name : NOBIZIDES

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : NOBIZIDES

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/12.5 mg

Price Per Pack (Euro) : 8.18

Published in :

Country : Italy

RX/OTC/DISCN :

blank

09

Brand Name : ALONEB

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : ALONEB

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/25 mg

Price Per Pack (Euro) : 8.18

Published in :

Country : Italy

RX/OTC/DISCN :

blank

10

Brand Name : LOBIDIUR

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : LOBIDIUR

Italy
arrow
AACR Annual meeting
Not Confirmed

Nebivolol; Hydrochlorothiazide

Dosage Form : Film-Coated Tablets

Dosage Strength : 5 mg/25 mg

Price Per Pack (Euro) : 8.18

Published in :

Country : Italy

RX/OTC/DISCN :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

ABBVIE

U.S.A

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

US Patent Number : 7838552

Drug Substance Claim :

Drug Product Claim :

Application Number : 206302

Patent Use Code : U-185

Delist Requested :

Patent Use Description : METHOD OF TREATING HYP...

Patent Expiration Date : 2027-10-04

Abbvie Company Banner

02

ABBVIE

U.S.A

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

US Patent Number : 7803838

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206302

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-29

Abbvie Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Others

read-more
read-more

01

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Hydrochloride (150 mg)

CAS Number : 152520-56-4

Quantity Per Vial : 150

Sale Unit : mg

Price : $1,450. 00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457833 / F027M0

blank

02

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Related Compound A (30 mg) (See USP...

CAS Number :

Quantity Per Vial : 30

Sale Unit : mg

Price : $877.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457855 / F027N0

blank

03

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Related Compound B (30 mg) (See USP...

CAS Number :

Quantity Per Vial : 30

Sale Unit : mg

Price : $877.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457866 / F027P0

blank

04

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Related Compound C (100 mg) (COLD S...

CAS Number : 876514-31-7

Quantity Per Vial : 100

Sale Unit : mg

Price : $877.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457877 / F027Q0

blank

05

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Related Compound D (100 mg) ((RS)-6...

CAS Number : 793669-26-8

Quantity Per Vial : 100

Sale Unit : mg

Price : $814.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457888 / F027R0

blank

06

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

XYZ Pharma

Gabon
arrow
AACR Annual meeting
Not Confirmed

Nebivolol Related Compound E (30 mg) (1-(Chro...

CAS Number :

Quantity Per Vial : 30

Sale Unit : mg

Price : $814.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1457899 / F027S0

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 152520-56-4 / Nebivolol API manufacturers, exporters & distributors?

Nebivolol manufacturers, exporters & distributors 1

14

PharmaCompass offers a list of Nebivolol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nebivolol manufacturer or Nebivolol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nebivolol manufacturer or Nebivolol supplier.

API | Excipient name

Nebivolol

Synonyms

169293-50-9, Nebivolol hcl, 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) hydrochloride, 152520-56-4, Rac nebivolol hydrochloride, R 065824 hydrochloride

Cas Number

152520-56-4

About Nebivolol

A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.

Nebivolol HCl Manufacturers

A Nebivolol HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nebivolol HCl, including repackagers and relabelers. The FDA regulates Nebivolol HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nebivolol HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nebivolol HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Nebivolol HCl Suppliers

A Nebivolol HCl supplier is an individual or a company that provides Nebivolol HCl active pharmaceutical ingredient (API) or Nebivolol HCl finished formulations upon request. The Nebivolol HCl suppliers may include Nebivolol HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Nebivolol HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Nebivolol HCl USDMF

A Nebivolol HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Nebivolol HCl active pharmaceutical ingredient (API) in detail. Different forms of Nebivolol HCl DMFs exist exist since differing nations have different regulations, such as Nebivolol HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Nebivolol HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Nebivolol HCl USDMF includes data on Nebivolol HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nebivolol HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Nebivolol HCl suppliers with USDMF on PharmaCompass.

Nebivolol HCl KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Nebivolol HCl Drug Master File in Korea (Nebivolol HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nebivolol HCl. The MFDS reviews the Nebivolol HCl KDMF as part of the drug registration process and uses the information provided in the Nebivolol HCl KDMF to evaluate the safety and efficacy of the drug.

After submitting a Nebivolol HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nebivolol HCl API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Nebivolol HCl suppliers with KDMF on PharmaCompass.

Nebivolol HCl CEP

A Nebivolol HCl CEP of the European Pharmacopoeia monograph is often referred to as a Nebivolol HCl Certificate of Suitability (COS). The purpose of a Nebivolol HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nebivolol HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nebivolol HCl to their clients by showing that a Nebivolol HCl CEP has been issued for it. The manufacturer submits a Nebivolol HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nebivolol HCl CEP holder for the record. Additionally, the data presented in the Nebivolol HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nebivolol HCl DMF.

A Nebivolol HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nebivolol HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Nebivolol HCl suppliers with CEP (COS) on PharmaCompass.

Nebivolol HCl WC

A Nebivolol HCl written confirmation (Nebivolol HCl WC) is an official document issued by a regulatory agency to a Nebivolol HCl manufacturer, verifying that the manufacturing facility of a Nebivolol HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nebivolol HCl APIs or Nebivolol HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Nebivolol HCl WC (written confirmation) as part of the regulatory process.

click here to find a list of Nebivolol HCl suppliers with Written Confirmation (WC) on PharmaCompass.

Nebivolol HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nebivolol HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Nebivolol HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Nebivolol HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Nebivolol HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nebivolol HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Nebivolol HCl suppliers with NDC on PharmaCompass.

Nebivolol HCl GMP

Nebivolol HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nebivolol HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nebivolol HCl GMP manufacturer or Nebivolol HCl GMP API supplier for your needs.

Nebivolol HCl CoA

A Nebivolol HCl CoA (Certificate of Analysis) is a formal document that attests to Nebivolol HCl's compliance with Nebivolol HCl specifications and serves as a tool for batch-level quality control.

Nebivolol HCl CoA mostly includes findings from lab analyses of a specific batch. For each Nebivolol HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nebivolol HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Nebivolol HCl EP), Nebivolol HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nebivolol HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty